A Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic Metastases

NCT00542048 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Cancer
Neoplasm Metastasis

Interventions

DRUG: EndoTAG®-1

Sponsor

MediGene